Regeneron Pharmaceuticals, Inc.
WHO'M
ai
Digital Profiler. Einfach den AI-Button klicken
FIGI: BBG000C734W3
REGN
Regeneron Pharmaceuticals, Inc.
GICS: -
·
Sektor: Healthcare
·
Sub-Sektor: Biotechnology
NAME
Regeneron Pharmaceuticals, Inc.
ISIN
US75886F1075
TICKER
REGN
MIC
XNAS
REUTERS
REGN.OQ
BLOOMBERG
REGN US
Financial Intelligence
FÜR INVESTOREN
FÜR TRADER
Börsenhandel
Warrants
Der X-News Explorer ist die ultimative Informationsquelle für börsenaffine Anleger, die sich schnell und komfortabel einen Überblick über die aktuelle Nachrichtenlage eines börsennotierten Unternehmens verschaffen möchten. Ihnen stehen hier verschiedene Newswire-Services zur Verfügung. Wird ein News-Alert angezeigt, liegen Unternehmensnachrichten vor, die Sie möglicherweise interessieren könnten. Dieser Service wird Ihnen von BusinessWire bereitgestellt.
Mo., 04.11.2024
Regeneron Pharmaceuticals
US75886F1075
Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Regeneron Pharmaceuticals, Inc. (“Regeneron” or the “Company”) (NASDAQ: REGN) investors concerning the Company’s possible violations of the federal securities laws.
If you suffered a loss on ...
Regeneron Pharmaceuticals
Mo., 04.11.2024
Regeneron Pharmaceuticals
US75886F1075
Law Offices of Howard G. Smith announces an investigation on behalf of Regeneron Pharmaceuticals, Inc. (“Regeneron” or the “Company”) (NASDAQ: REGN) investors concerning the Company’s possible violations of federal securities laws.
On April 10, 2024, the US Department of Justice (“DOJ”) announced the United States had filed a complaint against Re...
Regeneron Pharmaceuticals
Fr., 01.11.2024
Regeneron Pharmaceuticals
US75886F1075
The Law Offices of Frank R. Cruz continues its investigation of Regeneron Pharmaceuticals, Inc. (“Regeneron” or the “Company”) (NASDAQ: REGN) on behalf of investors concerning the Company’s possible violations of federal securities laws.
If you are a shareholder who suffered a loss, click here to participate.
On April 10, 2024, the US Department...
Regeneron Pharmaceuticals
Informationen zu Product Placements
